Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: A systematic scoping review

Blood Reviews

Volumn 30, Issue 6, 2016, Pages 411-420

  Hayden, Anna ^a   Park, Sujin ^a   Giustini, Dean ^a   Lee, Agnes Y Y ^a   Chen, Luke Y C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adults; Hematophagic histiocytosis; Hemophagocytic lymphohistiocytosis; Hemophagocytic syndromes; Hyperferritinemia; Macrophage activation syndromes

Indexed keywords

DOXORUBICIN; ETOPOSIDE; SOLUBLE INTERLEUKIN 2 RECEPTOR; STEROID;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; CELL FUNCTION; DRUG RESPONSE; HEMOPHAGOCYTIC SYNDROME; HUMAN; NATURAL KILLER CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREND STUDY; DISEASE PREDISPOSITION; META ANALYSIS; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PROGNOSIS;

COMBINED MODALITY THERAPY; DISEASE SUSCEPTIBILITY; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; TREATMENT OUTCOME;

EID: 84969964497     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2016.05.001     Document Type: Review

References (91)

1. [1] Buyse, S., Teixeira, L., Galicier, L., Mariotte, E., Lemiale, V., Seguin, A., et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 36:10 (2010), 1695–1702.
2. [2] Jaffe, R., The histiocytoses. Clin Lab Med 19:1 (1999), 135–155.
3. [3] Stepp, S.E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, P.A., et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286:5446 (1999), 1957–1959.
4. [4] Voskoboinik, I., Smyth, M.J., Trapani, J.A., Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 6:12 (2006), 940–952.
5. [5] Feldmann, J., Callebaut, I., Raposo, G., Certain, S., Bacq, D., Dumont, C., et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115:4 (2003), 461–473.
6. [6] zur Stadt, U., Rohr, J., Seifert, W., Koch, F., Grieve, S., Pagel, J., et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet 85:4 (2009), 482–492.
7. [7] zur Stadt, U., Schmidt, S., Kasper, B., Beutel, K., Diler, A.S., Henter, J.I., et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum Mol Genet 14:6 (2005), 827–834.
8. [8] Emmenegger, U., Schaer, D.J., Larroche, C., Neftel, K.A., Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 135:21–22 (2005), 299–314.
9. [9] Ueda, I., Kurokawa, Y., Koike, K., Ito, S., Sakata, A., Matsumora, T., et al. Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations. Am J Hematol 82:6 (2007), 427–432.
10. [10] Zhang, K., Jordan, M.B., Marsh, R.A., Johnson, J.A., Kissell, D., Meller, J., et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood 118:22 (2011), 5794–5798.
11. [11] Clementi, R., Emmi, L., Maccario, R., Liotta, F., Moretta, L., Danesino, C., et al. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 100:6 (2002), 2266–2267.
12. [12] Henter, J.I., Horne, A., Arico, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:2 (2007), 124–131.
13. [13] Fukaya, S., Yasuda, S., Hashimoto, T., Oku, K., Kataoka, H., Horita, T., et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology 47:11 (2008), 1686–1691.
14. [14] Emmenegger, U., Reimers, A., Frey, U., Fux, C., Bihl, F., Semela, D., et al. Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly 132:17–18 (2002), 230–236.
15. [15] Strauss, R., Neureiter, D., Westenburger, B., Wehler, M., Kirchner, T., Hahn, E.G., Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients—a postmortem clinicopathologic analysis. Crit Care Med 32:6 (2004), 1316–1321.
16. [16] Francois, B., Trimoreau, F., Vignon, P., Fixe, P., Praloran, V., Gastinne, H., Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 103:2 (1997), 114–120.
17. [17] Ho, C., Yao, X., Tian, L., Li, F.Y., Podoltsev, N., Xu, M.L., Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am J Clin Pathol 141:1 (2014), 62–71.
18. [18] Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheum 66:9 (2014), 2613–2620.
19. [19] Parikh, S.A., Kapoor, P., Letendre, L., Kumar, S., Wolanskyj, A.P., Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 89:4 (2014), 484–492.
20. [20] Tsuda, H., Hemophagocytic syndrome (HPS) in children and adults. Int J Hematol 65:3 (1997), 215–226.
21. [21] Hejblum, G., Lambotte, O., Galicier, L., Coppo, P., Marzac, C., Aumont, C., et al. A web-based Delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients. PLoS One, 9(4), 2014, e94024.
22. [22] Gratton, S.M., Powell, T.R., Theeler, B.J., Hawley, J.S., Amjad, F.S., Tornatore, C., Neurological involvement and characterization in acquired hemophagocytic lymphohistiocytosis in adulthood. J Neurol Sci 357:1–2 (2015), 136–142.
23. [23] Henter, J.I., Samuelsson-Horne, A., Arico, M., Egeler, R.M., Elinder, G., Filipovich, A.H., et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100:7 (2002), 2367–2373.
24. [24] Ramos-Casals, M., Brito-Zeron, P., Lopez-Guillermo, A., Khamashta, M.A., Bosch, X., Adult haemophagocytic syndrome. Lancet 383:9927 (2014), 1503–1516.
25. [25] Schram, A.M., Berliner, N., How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood 125:19 (2015), 2908–2914.
26. [26] Jordan, M.B., Allen, C.E., Weitzman, S., Filipovich, A.H., McClain, K.L., How I treat hemophagocytic lymphohistiocytosis. Blood 118:15 (2011), 4041–4052.
27. [27] Cascio, A., Pernice, L.M., Barberi, G., Delfino, D., Biondo, C., Beninati, C., et al. Secondary hemophagocytic lymphohistiocytosis in zoonoses. A systematic review. Eur Rev Med Pharmacol Sci 16:10 (2012), 1324–1337.
28. [28] Atteritano, M., David, A., Bagnato, G., Beninati, C., Frisina, A., Iaria, C., et al. Haemophagocytic syndrome in rheumatic patients. A systematic review. Eur Rev Med Pharmacol Sci 16:10 (2012), 1414–1424.
29. [29] Rajagopala, S., Dutta, U., Chandra, K.S.P., Bhatia, P., Varma, N., Kochhar, R., Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis — case report and systematic review. J Infect 56:5 (2008), 381–388.
30. [30] Arksey, H., O'Malley, L., Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8:1 (2005), 19–32.
31. [31] McGaghie, W.C., Varieties of integrative scholarship: why rules of evidence, criteria, and standards matter. Acad Med 90:3 (2015), 294–302.
32. [32] Levac, D., Colquhoun, H., O'Brien, K.K., Scoping studies: advancing the methodology. Implement Sci 5:1 (2010), 1–9.
33. [33] Wang, Y., Wang, Z., Wu, L., Zhang, J., Wang, J., Yan, L., Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis. Ann Hematol 92:12 (2013), 1695–1699.
34. [34] Wang, Y., Huang, W., Hu, L., Cen, X., Li, L., Wang, J., et al. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood 126:19 (2015), 2186–2192.
35. [35] Stephan, F., Thioliere, B., Verdy, E., Tulliez, M., Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock. Clin Infect Dis 25:5 (1997), 1159–1164.
36. [36] Mazodier, K., Marin, V., Novick, D., Farnarier, C., Robitail, S., Schleinitz, N., et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 106:10 (2005), 3483–3489.
37. [37] Beutel, G., Wiesner, O., Eder, M., Hafer, C., Schneider, A.S., Kielstein, J.T., et al. Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection. Crit Care, 15(2), 2011, R80.
38. [38] Delavigne, K., Berard, E., Bertoli, S., Corre, J., Duchayne, E., Demur, C., et al. Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy. Haematologica 99:3 (2014), 474–480.
39. [39] Fardet, L., Lambotte, O., Meynard, J.L., Kamouh, W., Galicier, L., Marzac, C., et al. Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis. AIDS 24:9 (2010), 1299–1306.
40. [40] Wang, Z., Wang, Y., Wang, J., Feng, C., Tian, L., Wu, L., Early diagnostic value of low percentage of glycosylated ferritin in secondary hemophagocytic lymphohistiocytosis. Int J Hematol 90:4 (2009), 501–505.
41. [41] Chen, W., Zhang, S., Zhang, W., Yang, X., Xu, J., Qiu, H., et al. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis. Int J Lab Hematol 37:4 (2015), 544–550.
42. [42] Ohno, T., Ueda, Y., Nagai, K.I., Takahashi, T., Konaka, Y., Takamatsu, T., et al. The serum cytokine profiles of lymphoma-associated hemophagocytic syndrome: a comparative analysis of B-cell and T-cell/natural killer cell lymphomas. Int J Hematol 77:3 (2003), 286–294.
43. [43] Chandrakasan, S., Marsh, R.A., Bellman, D., Grimley, M., Bleesing, J., Jordan, M., et al. Outcome of hematopoietic cell transplant for hemophagocytic lymphohistiocytosis in adults: a single center experience. Biol Blood Marrow Transplant, 19(2 SUPPL.1), 2013, S284.
44. [44] Chandrakasan, S., Grimley, M., Bleesing, J., Jordan, M., Filipovich, A., Adolescents and young adults with hemophagocytic lymphohistiocytosis who undergo allogeneic hematopoietic cell transplantation are at increased risk of mortality compared to younger patients. Blood, 122(21), 2013, 2087.
45. [45] Fardet, L., Galicier, L., Vignon-Pennamen, M.D., Regnier, S., Noguera, M.E., de Labarthe, A., et al. Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndrome. Br J Dermatol 162:3 (2010), 547–553.
46. [46] Arca, M., Fardet, L., Galicier, L., Riviere, S., Marzac, C., Aumont, C., et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide. Br J Haematol 168:1 (2015), 63–68.
47. [47] Riviere, S., Galicier, L., Coppo, P., Marzac, C., Aumont, C., Lambotte, O., et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med 127:11 (2014), 1118–1125.
48. [48] Fardet, L., Coppo, P., Kettaneh, A., Dehoux, M., Cabane, J., Lambotte, O., Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome. Arthritis Rheum 58:5 (2008), 1521–1527.
49. [49] Aulagnon, F., Lapidus, N., Canet, E., Galicier, L., Boutboul, D., Peraldi, M.N., et al. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis. Am J Kidney Dis 65:6 (2015), 851–859.
50. [50] Ishii, E., Ohga, S., Imashuku, S., Yasukawa, M., Tsuda, H., Miura, I., et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 86:1 (2007), 58–65.
51. [51] Machaczka, M., Vaktnas, J., Klimkowska, M., Hagglund, H., Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center. Leuk Lymphoma 52:4 (2011), 613–619.
52. [52] Henter, J.I., Elinder, G., Ost, A., Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 18:1 (1991), 29–33.
53. [53] Akashi, K., Hayashi, S., Gondo, H., Mizuno, S.I., Harada, M., Tamura, K., et al. Involvement of interferon-gamma and macrophage colony-stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults. Br J Haematol 87:2 (1994), 243–250.
54. [54] Majluf-Cruz, A., Sosa-Camas, R., Perez-Ramirez, O., Rosas-Cabral, A., Vargas-Vorackova, F., Labardini-Mendez, J., Hemophagocytic syndrome associated with hematological neoplasias. Leuk Res 22:10 (1998), 893–898.
55. [55] Imashuku, S., Kuriyama, K., Sakai, R., Nakao, Y., Masuda, S., Yasuda, N., et al. Treatment of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol 41:2 (2003), 103–109.
56. [56] Kuriyama, T., Takenaka, K., Kohno, K., Yamauchi, T., Daitoku, S., Yoshimoto, G., et al. Engulfment of hematopoietic stem cells caused by down-regulation of CD47 is critical in the pathogenesis of hemophagocytic lymphohistiocytosis. Blood 120:19 (2012), 4058–4067.
57. [57] Sieni, E., Cetica, V., Piccin, A., Gherlinzoni, F., Sasso, F.C., Rabusin, M., et al. Familial hemophagocytic lymphohistiocytosis may present during adulthood: clinical and genetic features of a small series. PLoS One, 7(9), 2012, e44649.
58. [58] Otrock, Z.K., Eby, C.S., Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis. Am J Hematol 90:3 (2015), 220–224.
59. [59] Otrock, Z.K., Gonzalez, M.D., Eby, C.S., Ehrlichia-induced hemophagocytic lymphohistiocytosis: a case series and review of literature. Blood Cells Mol Dis 55:3 (2015), 191–193.
60. [60] Huasong, Z., Ping, W., Xiangyuan, C., Yandan, W., Clinical features and perforin A91V gene analysis in 31 patients with macrophage activation syndrome and systemic juvenile idiopathic arthritis in China. J Rheumatol 40:7 (2013), 1238–1239.
61. [61] Jing-Shi, W., Yi-Ni, W., Lin, W., Zhao, W., Splenectomy as a treatment for adults with relapsed hemophagocytic lymphohistiocytosis of unknown cause. Ann Hematol 94:5 (2015), 753–760.
62. [62] Wang, Y., Wang, Z., Zhang, J., Wei, Q., Tang, R., Qi, J., et al. Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood. PLoS One, 9(9), 2014, e107386.
63. [63] Tsuji, T., Hirano, T., Yamasaki, H., Tsuji, M., Tsuda, H., A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome. Ann Hematol 93:5 (2014), 821–826.
64. [64] Schram, A.M., Campigotto, F., Mullally, A., Fogerty, A., Massarotti, E., Neuberg, D., et al. Marked hyperferritinemia does not predict for HLH in the adult population. Blood 125:10 (2015), 1548–1552.
65. [65] Park, H.S., Kim, D.Y., Lee, J.H., Kim, S.D., Park, Y.H., Lee, J.S., et al. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors. Ann Hematol 91:6 (2012), 897–904.
66. [66] Imashuku, S., Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 66:2 (1997), 135–151.
67. [67] Emmenegger, U., Frey, U., Reimers, A., Fux, C., Semela, D., Cottagnoud, P., et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 68:1 (2001), 4–10.
68. [68] Takagi, S., Masuoka, K., Uchida, N., Ishiwata, K., Araoka, H., Tsuji, M., et al. High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. Br J Haematol 147:4 (2009), 543–553.
69. [69] Dalal, B.I., Vakil, A.P., Khare, N.S., Wang, S.Y., Richards, M.J., Chen, L.Y., Abnormalities of the lymphocyte subsets and their immunophenotype, and their prognostic significance in adult patients with hemophagocytic lymphohistiocytosis. Ann Hematol 94:7 (2015), 1111–1117.
70. [70] Shin, H.J., Joo, S.C., Lee, J.J., Sang, K.S., Young, J.C., Kim, Y.K., et al. Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis. J Korean Med Sci 23:3 (2008), 439–444.
71. [71] Takahashi, N., Chubachi, A., Kume, M., Hatano, Y., Komatsuda, A., Kawabata, Y., et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 74:2 (2001), 209–213.
72. [72] Imashuku, S., Kuriyama, K., Teramura, T., Ishii, E., Kinugawa, N., Kato, M., et al. Requirement for etoposide in the treatment of Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 19:10 (2001), 2665–2673.
73. [73] Li, J., Wang, Q., Zheng, W., Ma, J., Zhang, W., Wang, W., et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine 93:2 (2014), 100–105.
74. [74] Nair, V., Das, S., Sharma, A., Sharma, S., Sharma, P., Ray, S., et al. A clinicopathological analysis of 26 patients with infection-associated haemophagocytic lymphohistiocytosis and the importance of bone marrow phagocytosis for the early initiation of immunomodulatory treatment. Postgrad Med J 89:1050 (2012), 185–192.
75. [75] He, A., Zhang, W., Niu, Y., Wang, J., Chao, X., Yang, Y., When should hemodialysis or plasma exchange be used to reduce early death in hemophagocytic lymphohistiocytosis?. Int Med J 19:1 (2012), 27–30.
76. [76] Li, F., Li, P., Zhang, R., Yang, G., Ji, D., Huang, X., et al. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China. Med Oncol, 31(4), 2014, 902.
77. [77] Yu, J.T., Wang, C.Y., Yang, Y., Wang, R.C., Chang, K.H., Hwang, W.L., et al. Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution. Ann Hematol 92:11 (2013), 1529–1536.
78. [78] Han, A.R., Lee, H.R., Park, B.B., Hwang, I.G., Park, S., Lee, S.C., et al. Lymphoma-associated hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol 86:7 (2007), 493–498.
79. [79] Kaito, K., Kobayashi, M., Katayama, T., Otsubo, H., Ogasawara, Y., Sekita, T., et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 59:4 (1997), 247–253.
80. [80] Wormsbecker, A.J., Sweet, D.D., Mann, S.L., Wang, S.Y., Pudek, M.R., Chen, L.Y., Conditions associated with extreme hyperferritinaemia (> 3000 mug/L) in adults. Intern Med J 45:8 (2015), 828–833.
81. [81] Gupta, A., Weitzman, S., Abdelhaleem, M., The role of hemophagocytosis in bone marrow aspirates in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 50:2 (2008), 192–194.
82. [82] Zoller, E.E., Lykens, J.E., Terrell, C.E., Aliberti, J., Filipovich, A.H., Henson, P.M., et al. Hemophagocytosis causes a consumptive anemia of inflammation. J Exp Med 208:6 (2011), 1203–1214.
83. [83] NovImmune SA. Long-term follow-up of HLH patients who received treatment with NI-0501, an anti-interferon gamma monoclonal antibody. https://clinicaltrials.gov/ct2/show/NCT02069899.
84. [84] Children's Hospital Medical Center Cincinnati. Hybrid immunotherapy for hemophagocytic lymphohistiocytosis. https://clinicaltrials.gov/ct2/show/NCT01104025.
85. [85] Bodley Scott, R., Smith, A.H.T., Histiocytic medullary reticulocytosis. Lancet, 1939, 234519–234525.
86. [86] Farquhar, J.W., Claireaux, A.E., Familial haemophagocytic reticulosis. Arch Dis Child 27:136 (1952), 519–525.
87. [87] Jaffe, E.S., Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology. Mod Pathol 14:3 (2001), 219–228.
88. [88] Risdall, R.J., McKenna, R.W., Nesbit, M.E., Krivit, W., Balfour, H.H. Jr., Simmons, R.L., et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:3 (1979), 993–1002.
89. [89] Winkelmann, R.K., Bowie, E.J., Hemorrhagic diathesis associated with benign histiocytic, cytophagic panniculitis and systemic histiocytosis. Arch Intern Med 140:11 (1980), 1460–1463.
90. [90] Janka, G.E., Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 140:3 (1983), 221–230.
91. [91] Stephan, J.L., Zeller, J., Hubert, P., Herbelin, C., Dayer, J.M., Prieur, A.M., Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol 11:4 (1993), 451–456.